Breaking Biodefense News: Aethlon Medical (NASDAQ:OTCQB: AEMD) Receives Notice of DARPA Contract Renewal

SAN DIEGO - September 22, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (NASDAQ:OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that the Defense Advanced Research Projects Agency (DARPA) has informed the Company that it plans to exercise an option to proceed with year four of a five-year $5.9 million contract that was awarded to Aethlon on September 30, 2011 under DARPA's Dialysis-Like Therapeutics (DLT) program.

The fourth year of Aethlon's DLT contract contains three milestones representing a potential of $669,292 in revenue opportunity. To date, Aethlon has invoiced $4,252,037 to DARPA for achieving twenty of twenty-three milestone objectives targeted in the first three years of the DLT program.

Read more: Aethlon Medical ( AEMD )

Breaking Tech News: NXT-ID's (NASDAQ:NXTD) Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie

SHELTON, Conn. - September 19, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (NASDAQ: NXTD and NXTDW) ("Nxt-ID" or the "Company"), a biometric authentication company focused on the growing m-commerce market, updates the "Wocket in Your Pocket" celebrity ad campaign, featuring former boxer and world champion in the lightweight and light middleweight weight classes, Vinny Pazienza (PAZ).

Yesterday it was announced that Game of Thrones actor Ciaran Hinds and Sons of Anarchy and Married with Children star Katey Sagal have been cast in Bleed for This.

Read more: Breaking Tech News: NXT-ID's (NASDAQ:NXTD) Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and...

Medical Technology Breaking News: Aethlon Medical, Inc. (OTCQB: AEMD) - "The Identification of Neurological Disorders in NFL Players"

New York, NY - September 16, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD) today published a new blog post on The Chairman’s Blog, written by the Company’s Chairman and Chief Executive Officer, James A Joyce. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his new blog, Mr. Joyce expands on the Exosome Sciences blood-based "liquid biopsy" to potentially identify and monitor CTE in a living person. Mr. Joyce reflects on the impact this diagnostic can have on the future of advancing candidate therapies to treat CTE and what this can mean for Aethlon Medical and its subsidiary Exosome Sciences. Read the full blog post from Mr. Joyce on TheChairmansBlog.com.

Read more: Aethlon Medical Inc ( AEMD )

Technology Alert; Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service

New York, NY - Point Roberts, WA – September 12,  2014 - Investorideas.com (www.investorideas.com) a global news source covering leading sectors including biometrics and mobile tech , issues commentary from analysts and experts on the  September 9th launch of Apple Pay, its new payment service . Alan Goode of Goode Intelligence, Janice Kephart, founder of the Secure Identity and Biometrics Association (SIBA) and CEO Gino Pereira of NXT-ID, Inc, (Nasdaq: NXTD) a company that is introducing its own biometric smart wallet that is separate from a smartphone.

Alan Goode of Goode Intelligence, a well- known expert in biometrics noted, “Although not a revolutionary announcement from Apple, the introduction of Apple Pay using Touch ID for biometrically authenticated payments is a huge step towards the widespread adoption of mobile payments. Following on from the decision by PayPal and Alipay to both offer mobile payments to be authorised by fingerprint biometrics on the latest Samsung devices this is an indication that payments is a big driver for the adoption of consumer biometric authentication.”

Read more: Technology Alert; Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service

Breaking Tech News: NXT-ID (NASDAQ: NXTD) Commences Trading on NASDAQ Capital Market

SHELTON, CT - September 11, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (Nasdaq: NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that its shares of common stock and warrants to purchase common stock have commenced trading on The Nasdaq Capital Market. The common stock and warrants and will trade under the symbols "NXTD" and "NXTDW," respectively. As of today, the Company's common stock will no longer be quoted on the OTCQB, and shares previously quoted on the OTCQB will now be traded on Nasdaq.

Read this release in full at http://www.investorideas.com/CO/NXT/news/2014/09111.asp

Read more: NXT-ID ( NXTD )